中文版 | English

在结果中检索

CCPortal

浏览/检索结果: 共3条，第1-3条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载：38/0  |  提交时间：2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes  
Upregulation of a KN1 homolog by transposon insertion promotes leafy head development in lettuce 期刊论文
Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 117, 期号: 52
作者:  Yu C.;  Yan C.;  Liu Y.;  Liu Y.;  Jia Y.;  Lavelle D.;  An G.;  Zhang W.;  Zhang L.;  Han R.;  Larkin R.M.;  Chen J.;  Michelmore R.W.;  Kuang H.
收藏  |  浏览/下载：68/0  |  提交时间：2021/05/24
An unconventional role of an ASB family protein in NF-κB activation and inflammatory response during microbial infection and colitis 期刊论文
Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 118, 期号: 3
作者:  Hou P.;  Jia P.;  Yang K.;  Li Z.;  Tian T.;  Lin Y.;  Zeng W.;  Xing F.;  Chen Y.;  Li C.;  Liu Y.;  Guo D.
收藏  |  浏览/下载：18/0  |  提交时间：2021/05/24